Israel - English - Ministry of Health

taro international ltd, israel - clotiapine - tablets - clotiapine 40 mg - clotiapine - clotiapine - for the treatment of severe mental and emotional disorders (neuroleptic).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (south africa) - clotiapine - oral tablet - 40mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - clotiapine - oral tablet - 40mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires juvise pharmaceuticals - clotiapine 40 mg - tablet - 40 mg - clotiapine 40 mg - clotiapine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires juvise pharmaceuticals - clotiapine 40 mg/4 ml - solution for injection - 40 mg/4 ml - clotiapine 40 mg - clotiapine

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharmaco distribution (pty) ltd - injection - see ingredients - each 4 ml solution contains clotiapine 40 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharmaco distribution (pty) ltd - tablet - see ingredients - each tablet contains clotiapine 40,0 mg

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - clonidine 0.1 mg in 1 d - clonidine transdermal system is indicated in the treatment of hypertension. it may be employed alone or concomitantly with other antihypertensive agents. clonidine transdermal system should not be used in patients with known hypersensitivity to clonidine or to any other component of the transdermal system.

United States - English - NLM (National Library of Medicine)

accord healthcare inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozapine is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, clozapine should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)] . the effectiveness of clozapine in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)] . clozapine is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judge

United States - English - NLM (National Library of Medicine)

sandoz inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozapine tablets are indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, clozapine tablets should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)] . the effectiveness of clozapine tablets in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)] . clozapine tablets are indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at